PRECOS Appoints Dr Neil Rotherham as Chairman

Preclinical Oncology Services Limited (PRECOS), announces the appointment of Dr Neil Rotherham as Chairman of the Board. Dr Rotherham has over 20 years’ leadership experience in the life sciences, medical, pharmaceutical and biopharmaceutical sectors. He was responsible for developing and growing ClinPhone plc, from a twoperson start-up in 1993 to a 500-person global venture that was listed on the London Stock Exchange in 2006. Dr Rotherham left the business after bringing through a management team to run the business subsequent to going public.

"PRECOS combines the innovation of one of the Country’s leading universities (Nottingham) with the scientific background and expertise of multi-disciplinary scientists." said Dr Rotherham. "This places the company in an optimal position to deliver specialist services, backed by significant industry expertise and cutting-edge technology, to help both pharmaceutical and biotechnology companies develop new anti-cancer drugs." He continues: "PRECOS occupies a niche in global pre-clinical R&D working with unique patient-relevant models closely reflecting the patient situation. Tumour development can be monitored in real-time, allowing companies to concentrate efforts on those compounds most likely to have a therapeutic effect in patients with cancer."